Aim: Rectus sheath hematoma is a rare clinical condition. Because it could mimic various intra-abdominal pathologies suspicious approach and attention is needed for proper diagnosis and management of rectus sheath hematoma. The aim of this study is a review of factors affecting mortality in patients with rectus sheath hematoma besides clinical features, diagnosis modalities, treatment periods and results of patients with rectus sheath hematoma. Material and Method: Twenty-three patients with rectus sheath hematoma from January 2012 to March 2017 in a tertiary care center were included in the study. Patients' files were reviewed retrospectively. Reviewed variables were demographic and clinical features, symptom and findings, co-morbidities, medications, laboratory findings, diagnostic modalities, APACHE II scores, treatment approaches, transfused blood products and length of hospital stay. Results: Fifteen (65.2%) of the patients were women, and 8 (34.8%) of the patients were men. The mean age was 61.9 ±13.5. Seventeen (74%) of the patients had abdominal pain. Twenty (87%) of the patients had anticoagulant and antiplatelet therapy.The mean hematoma diameter was 6.3± 3.6 cm. The mean APACHE II score for the patients was 13.1±7.3. One patient had undergone surgery. There was mortality in 3 (13%) of the patients. The median length of stay in hospital was 5 (5) days. Discussion: The diagnosis of rectus sheath hematoma should be kept in mind while assessing old female patients and patients on anticoagulants with a complaint of abdominal pain. In our study, we identify risk factors such as higher APACHE -II scores, the presence of a transient ischemic attack, need for transfusion of more units of packed erythrocytes and more extended hospital stay as factors associated with mortality.
Introduction Rectus sheath hematoma (RSH) is a rare clinical condition that is caused by the occurrence of hematoma in rectus muscle or within muscle sheath following the injury to the branches of the superior epigastric artery. RSH could be observed after blunt or penetrating abdominal trauma, vigorous exercise, recent abdominal surgery, at trocar sites after laparoscopic surgery, abdominal wall injections, paracentesis or it could occur spontaneously in the presence of predisposing factors such as anticoagulation therapy and intractable coughing [1] . RSH could also mimic appendicitis or sepsis [2] . There are well-defined predisposing factors, clinical features, diagnostic classification by abdominal computerized tomography (CT) and treatment options for RSH in the literature [3] . However; there is lacking consensus about RSH related mortality and risk factors affecting mortality in patients with RSH. We aimed to investigate risk factors that influence mortality in patients with RSH primarily. The secondary purpose of this study is an overview of clinical characteristics, diagnosis modalities, treatment options and results of the patients with RSH.
Material and Method
Twenty-three patients with rectus sheath hematoma from January 2012 to March 2017 in a tertiary care center were included in the study. Patients' files were reviewed retrospectively. Exclusion criterion was pediatric age group (0-16 years old) patients. We described 54 variables such as age, gender, symptoms, and clinical findings of the patient, co-morbidities, medications, laboratory findings, diagnostic modality, CT classification, hematoma side, the diameter of hematoma, Acute Physiology and Chronic Health Evaluation (APACHE)-II score at the time of diagnosis, treatment options, transfused blood products, length of hospital stay (LOS) and presence of mortality after reviewing the files. We composed two independent groups due to the presence or absence of mortality to assess possible risk factors. clinical features are shown in Table 1 and Table 2 .
Mortality rate was 13%. The mean age was 53.3±7.5 (range 48-62), the mean Co-morbid disease numbers were 3.3± 1.1 (range: 2-4), the mean APACHE-II score was 27 ±4.5 (range: 23-32), the median transfused packed erythrocytes units were 9(0) (Range: 6-16 units), the median LOS days were 11(0) (range:
8-21 days) in mortality group. Conservative management was utilized for two of the patients and surgery was selected for one patient in the group.
We detected a significant difference between mortality and APACHE -II scores, the presence of a transient ischemic attack, LOS, and transfused units of packed erythrocytes. 
Discussion
We investigated factors affecting mortality and overviewed clinical features in the patients with RSH in this retrospective study. We found that mortality rate is 13% and this ratio is compatible with the literature. The mortality rate of the largest case series of 126 patients from Mayo Clinic was 1.6% [4] . The mortality rate in patients with RSH ranges from 0% to 14.7 % in various studies [5] . Villa et al. [6] reported that mortality rate was 17% among the patients who had to undergo surgery because of the hemodynamic instability of the patients. Carkman et al. [7] stated that the mortality rate could reach 20% in elderly and patients receiving anticoagulant therapy presenting with RSH. In this univariate analysis, we found that higher APACHE-II scores, the presence of TIA, need for more erythrocytes transfusion, and longer LOS are associated with the occurrence of mortality. We could not reveal significant differences between mortality and any variable in the multivariant analysis. While the median units of transfused erythrocytes were 3.5 units in the previous study [4] , our patients needed more erythrocytes transfusion (the median is nine units). The length of stay in hospital ranges from 4 to 10 days in previous studies [8] . In our study, the median LOS was 11 days in mortality group and 4.5 days in surviving group. We think that patients had to limit physiologic conditions beforehand resulting in more transfusions and longer stay in hospital in mortality group. Higara et al. [9] reported that mortality rate was 0.28% in ischemic stroke patients with RSH and they indicated that patients were receiving both antiplatelet and anticoagulant therapy. In our study, mortality occurred in two of the three TIA patients. While one of the mortality cases was receiving both antiplatelet and anticoagulant therapy, the other patient was receiving only anticoagulant therapy. However, we could not derive a relation between mortality and anticoagulant therapy. We noted that women to men ratio was 1.8:1 and is compatible with previous studies, nevertheless, we could not reveal any additional risk factor for female patients with RSH. The range of age was 46 -69 years in previous research [10] and the mean age was 61.9 ±13.5 (range: 31-87) in our study.
Patients developing RSH are mostly elderly, and this could be explained with these elderly patients being more liable to be on anticoagulant therapy. We also found lower INR levels than the previous study [4] . CT scan was performed for all patients except the pregnant one. CT scan is widely accepted as first-line diagnostic modality because of its superiority to ultrasound. Because it reveals hematoma size, location, and relation with peritoneum, CT scan could aid in shortening time for surgical decision-making period.
Most of the RSH patients were treated conservatively, that includes nil per os, intravascular hydration, bed rest and administering analgesics. Transcatheter embolization was performed for two patients, and surgery for hematoma drainage with bleeding control was conducted for one patient. Surgical decision-making depends on the hemodynamic instability of the patient with RSH [6] . Scoring systems such as APACHE-II could be used to decide which patient to take to surgery before developing hemodynamic instability. The study has some limitations: its retrospective in nature, a tertiary center analysis and a small number of patients that could have resulted in findings of higher mortality rate.
In conclusion, there are various predisposing factors for RSH. RSH should be kept in mind while evaluating geriatric female patients and patients on anticoagulant with a complaint of abdominal pain. Furthermore, we note that risk factors such as higher APACHE -II scores, the presence of TIA, transfusion of more units of packed erythrocytes and longer hospital stays are associated with an increase in mortality. 
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